First Time Loading...

BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 5.63 USD 5.83% Market Closed
Updated: May 14, 2024

BioCryst Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioCryst Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Gross Profit
$326.8m
CAGR 3-Years
173%
CAGR 5-Years
74%
CAGR 10-Years
34%
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.6B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is BioCryst Pharmaceuticals Inc's Gross Profit?
Gross Profit
326.8m USD

Based on the financial report for Dec 31, 2023, BioCryst Pharmaceuticals Inc's Gross Profit amounts to 326.8m USD.

What is BioCryst Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
34%

Over the last year, the Gross Profit growth was 24%. The average annual Gross Profit growth rates for BioCryst Pharmaceuticals Inc have been 173% over the past three years , 74% over the past five years , and 34% over the past ten years .